Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108849
Status:
COMPLETED
Last Update Posted:
2017-02-08
First Post:
2005-04-19
Brief Title:
Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A 12 Month Double-blind Randomized Parallel-group Placebo-controlled Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose 10 mcg 17beta-estradiol Vaginal Tablet for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in North America The purpose of this study is to determine if Vagifem Low Dose is an effective and safe treatment for patients suffering from postmenopausal atrophic vaginitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None